patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Thanks Patientman...

yes. You make a valid point. The NASDAQ listing is not written in stone. There are many hoops to jump through to qualify. The level of income is a good question.

Manolo

Share
New Message
Please login to post a reply